Page last updated: 2024-11-07

dextroamphetamine and Lupus Erythematosus, Systemic

dextroamphetamine has been researched along with Lupus Erythematosus, Systemic in 1 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klawans, HL1
Weiner, WJ1

Other Studies

1 other study available for dextroamphetamine and Lupus Erythematosus, Systemic

ArticleYear
The effect of d-amphetamine on choreiform movement disorders.
    Neurology, 1974, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Child; Chorea; Corpus Striatum; Dextroamphetamine; Dopamine; Evaluation Studies a

1974